SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Large Decrease in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 121,900 shares, a drop of 47.4% from the June 30th total of 231,800 shares. Based on an average daily volume of 295,700 shares, the days-to-cover ratio is presently 0.4 days. Currently, 3.3% of the shares of the company are short sold.

SeaStar Medical Price Performance

Shares of NASDAQ ICU traded up $0.91 during mid-day trading on Friday, reaching $8.80. 484,694 shares of the company traded hands, compared to its average volume of 256,616. SeaStar Medical has a fifty-two week low of $3.25 and a fifty-two week high of $42.92. The firm has a market cap of $28.34 million, a PE ratio of -0.35 and a beta of -1.07. The stock has a fifty day simple moving average of $7.70 and a 200-day simple moving average of $14.28.

SeaStar Medical (NASDAQ:ICU) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($4.75) EPS for the quarter.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.